New strategies for targeting the hypoxic tumour microenvironment in breast cancer

Carol Ward, Simon P Langdon, Peter Mullen, Adrian L Harris, David J Harrison, Claudiu T Supuran, Ian Kunkler

Research output: Contribution to journalArticlepeer-review

176 Citations (Scopus)


Radiation and drug resistance remain major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Metabolic reprogramming is a recently recognised hallmark of cancer with the hypoxic acidic extracellular environment as a major driver of invasion and metastases. Nearly 40% of all breast cancers and 50% of locally advanced breast cancers are hypoxic and their altered metabolism is strongly linked to resistance to radiotherapy and systemic therapy. The dependence of metabolically adapted breast cancer cells on alterations in cell function presents a wide range of new therapeutic targets such as carbonic anhydrase IX (CAIX). This review highlights preclinical approaches to evaluating an array of targets against tumour metabolism in breast cancer and early phase clinical studies on efficacy.
Original languageEnglish
Pages (from-to)171-179
Number of pages9
JournalCancer Treatment Reviews
Issue number2
Publication statusPublished - Apr 2013


  • Breast cancer
  • Tumour microenvironment
  • Metabolism
  • Warburg effect
  • Hypoxia
  • Radiology Nuclear Medicine and imaging
  • Oncology


Dive into the research topics of 'New strategies for targeting the hypoxic tumour microenvironment in breast cancer'. Together they form a unique fingerprint.

Cite this